RTTNews | Nov 10, 2021 08:28AM EST

08:28 Wednesday, November 10, 2021 (RTTNews.com) - Valneva SE (VALN), a French specialty vaccine company, said on Wednesday that the European Commission or EC has approved a deal pursuant to which Valneva would supply up to 60 million doses of VLA2001, inactivated Covid-19 vaccine candidate, over two years, including approximately 27 million doses in 2022.

According to the terms of the agreement, the EC has the option to increase its initial purchase in 2022, of VLA2001 up to a total of 60 million doses by the end of 2023.

The agreement will be completed following final review, including volumes required, by each of the EU member states.

The delivery of the vaccine is currently expected to begin in April 2022, subject to approval by the European Medicines Agency (EMA) human medicines committee (CHMP), which is expected to start a rolling review of VLA2001 shortly.

Read the original article on RTTNews ( https://www.rttnews.com/3241297/valneva-gets-ec-approval-for-advance-purchase-of-inactivated-covid-19-vaccine.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved